NDC | 72934-1072-2 |
Set ID | 883dde9f-e5dd-69d9-e053-2a95a90a2c24 |
Category | HUMAN PRESCRIPTION DRUG LABEL |
Packager | Sincerus Florida, LLC |
Generic Name | |
Product Class | |
Product Number | |
Application Number |
- Directions for use
- Sincerus Florida. Adverse reactions
- Active, inactive
- NDC 72934-1072-2 DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 4% Gel 30 gm
-
INGREDIENTS AND APPEARANCE
DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 4%
diclofenac sodium 3% / hyaluronic acid sodium salt 2% / niacinamide 4% gelProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72934-1072 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DICLOFENAC SODIUM (UNII: QTG126297Q) (DICLOFENAC - UNII:144O8QL0L1) DICLOFENAC SODIUM 3 g in 100 g Product Characteristics Color white (clear gel) Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72934-1072-2 30 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product 05/07/2019 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 05/07/2019 Labeler - Sincerus Florida, LLC (080105003) Establishment Name Address ID/FEI Business Operations Sincerus Florida, LLC 080105003 manufacture(72934-1072)